Loading clinical trials...
Loading clinical trials...
Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for obsessive compulsive...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Pennsylvania
Collaborators
NCT07622654 · OCD, Obsessive - Compulsive Disorder
NCT07124780 · Obsessive-Compulsive Disorder (OCD)
NCT06934525 · Obsessive Compulsive Disorder (OCD), Pediatric Anxiety Disorders, and more
NCT06997549 · Depression, OCD, and more
NCT06647589 · Obsessive-Compulsive Disorder (OCD)
New York State Psychiatric Institute
New York, New York
University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions